Clinical trial
Effect of Superba Krill on Inflammation in Patients With Coronary Artery Disease
NCT01092793 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Superba Krill on Inflammation in Patients With Coronary Artery Disease
- Lead sponsor
- Oslo University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- January 31, 2012
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stable atherosclerotic coronary disease